Your institution may have access to this item. Find your institution then sign in to continue.
Title
Shire acquires Foresight Biotherapeutics for $300 million.
Abstract
The article reports on the acquisition of privately held company Foresight Biotherapeutics by global specialty pharmaceutical firm Shire for 300 million dollars, as of August 2015.